Utility of sequencing the erm(41) gene in isolates of Mycobacterium abscessus subsp. abscessus with low and intermediate clarithromycin MICs

Journal of Clinical Microbiology

Volumn 53, Issue 4, 2015, Pages 1211-1215

  Brown Elliott, Barbara A ^a   Vasireddy, Sruthi ^a   Vasireddy, Ravikiran ^a   Iakhiaeva, Elena ^a   Howard, Susan T ^a   Nash, Kevin ^b   Parodi, Nicholas ^a   Strong, Anita ^a   Gee, Martha ^a   Smith, Terry ^a   Wallace, Richard J ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; MACROLIDE; ANTIINFECTIVE AGENT; METHYLTRANSFERASE; MUTANT PROTEIN; RRNA (ADENOSINE-O-2'-)METHYLTRANSFERASE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CONTROLLED STUDY; ERM GENE; GENE MUTATION; GENE SEQUENCE; HUMAN; INCUBATION TIME; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM ABSCESSUS; NONHUMAN; PRIORITY JOURNAL; UNITED STATES; ANTIBIOTIC RESISTANCE; DNA SEQUENCE; DRUG EFFECTS; ENZYMOLOGY; GENETICS; GENOTYPE; MICROBIAL SENSITIVITY TEST; MOLECULAR GENETICS; MYCOBACTERIUM;

MYCOBACTERIUM ABSCESSUS;

ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HUMANS; MACROLIDES; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; MYCOBACTERIUM; SEQUENCE ANALYSIS, DNA; UNITED STATES;

EID: 84925264399     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02950-14     Document Type: Article

References (16)

1. Bastian S, Veziris N, Roux A-L, Brossier F, Gaillard J-L, Jarlier V, Cambau E. 2011. Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing. Antimicrob Agents Chemother 55:775-781. http://dx.doi.org/10.1128/AAC.00861-10.
2. Kim H-Y, Kim BJ, Kook Y, Yun Y-J, Shin JH, Kim B-J, Kook Y-H. 2010. Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns. Microbiol Immunol 54:347-353. http://dx.doi.org/10.1111/j.1348-0421.2010.00221.x.
3. Tettelin H, Davidson RM, Agrawal S, Aitken ML, Shallom S, Hasan NA, Strong M, de Moura VCN, De Groote MA, Duarte RS, Hine E, Parankush S, Su Q, Daugherty SC, Fraser CM, Brown-Elliott BA, Wallace RJ, Jr, Holland SM, Sampaio EP, Olivier KN, Jackson M, Zelazny AM. 2014. High-level relatedness among Mycobacterium abscessus subsp. massiliense strains from widely separated outbreaks. Emerg Infect Dis 20:364-371. http://dx.doi.org/10.3201/eid2003.131106.
4. Nash KA, Brown-Elliott BA, Wallace RJ, Jr. 2009. A novel gene, erm (41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother 53:1367-1376. http://dx.doi.org/10.1128/AAC.01275-08.
5. Brown-Elliott BA, Vasireddy S, Vasireddy R, Iakhiaeva E, Parodi N, Strong A, Gee M, McNulty S, O'Neil S, Wallace RJ, Jr. 2014. Sequencing of the erm gene in isolates of Mycobacterium abscessus subspecies abscessus with low clarithromycin MICs, abstr 945. Abstr 114th Gen Meet Am Soc Microbiol. American Society for Microbiology, Washington, DC.
6. Adékambi T, Berger P, Raoult D, Drancourt M. 2006. rpoB gene sequence-based characterization of emerging non-tuberculous mycobacteria with descriptions of Mycobacterium bolletii sp. nov., M. phocaicum sp. nov. and Mycobacterium aubagnense sp. nov. Int J Syst Evol Microbiol 56:133-143. http://dx.doi.org/10.1099/ijs.0.63969-0.
7. Steingrube VA, Gibson JL, Brown BA, Zhang Y, Wilson RW, Rajagopalan M, Wallace RJ, Jr. 1995. PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria. J Clin Microbiol 33:149-153. (Erratum 33:1686.).
8. Telenti A, Marchesi F, Balz M, Bally F, Böttger EC, Bodmer T. 1993. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 31:175-178.
9. Clinical and Laboratory Standards Institute. 2011. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes: approved standard - 2nd ed. CLSI document M24-A2. CLSI, Wayne, PA.
10. Wallace RJ, Jr, Meier A, Brown BA, Zhang Y, Sander P, Onyi GO, Böttger EC. 1996. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother 40:1676-1681.
11. Nash KA, Andini N, Zhang Y, Brown-Elliott BA, Wallace RJ, Jr. 2006. Intrinsic macrolide resistance in rapidly growing mycobacteria. Antimicrob Agents Chemother 50:3476-3478. http://dx.doi.org/10.1128/AAC.00402-06.
12. Meier A, Heifets L, Wallace RJ, Jr, Zhang Y, Brown BA, Sander P, Böttger EC. 1996. Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population. J Infect Dis 174:354-360. http://dx.doi.org/10.1093/infdis/174.2.354.
13. Meier A, Kirschner P, Springer B, Steingrube VA, Brown BA, Wallace RJ, Jr, Böttger EC. 1994. Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob Agents Chemother 38:381-384. http://dx.doi.org/10.1128/AAC.38.2.381.
14. Burman WJ, Stone BL, Brown BA, Wallace RJ, Jr, Böttger EC. 1998. AIDS-related Mycobacterium kansasii infection with initial resistance to clarithromycin. Diagn Microbiol Infect Dis 31:369-371. http://dx.doi.org/10.1016/S0732-8893(98)00013-3.
15. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ, Jr, Winthrop K. 2007. An official ATS/IDSA statement: diagnosis, treatment and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175: 367-416. http://dx.doi.org/10.1164/rccm.200604-571ST.
16. Shallom SJ, Gardina PJ, Myers TG, Sebastian Y, Conville PS, Calhoun LB, Tettelin H, Olivier KN, Uzel G, Sampaio EP, Holland SM, Zelazny AM. 2013. New rapid scheme for distinguishing the subspecies of the Mycobacterium abscessus group and identification of Mycobacterium massiliense with inducible clarithromycin resistance. J Clin Microbiol 51: 2943-2949. http://dx.doi.org/10.1128/JCM.01132-13.